GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (BSP:T1EV34) » Definitions » ROE % Adjusted to Book Value

Teva Pharmaceutical Industries (BSP:T1EV34) ROE % Adjusted to Book Value : -8.75% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Teva Pharmaceutical Industries ROE % Adjusted to Book Value?

Teva Pharmaceutical Industries's ROE % for the quarter that ended in Sep. 2024 was -28.54%. Teva Pharmaceutical Industries's PB Ratio for the quarter that ended in Sep. 2024 was 3.26. Teva Pharmaceutical Industries's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -8.75%.


Teva Pharmaceutical Industries ROE % Adjusted to Book Value Historical Data

The historical data trend for Teva Pharmaceutical Industries's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries ROE % Adjusted to Book Value Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -35.22 5.06 -19.92 -4.55

Teva Pharmaceutical Industries Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.97 16.49 -3.40 -17.29 -8.75

Competitive Comparison of Teva Pharmaceutical Industries's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's ROE % Adjusted to Book Value falls into.



Teva Pharmaceutical Industries ROE % Adjusted to Book Value Calculation

Teva Pharmaceutical Industries's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-7.05% / 1.55
=-4.55%

Teva Pharmaceutical Industries's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-28.54% / 3.26
=-8.75%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Teva Pharmaceutical Industries ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Headlines

No Headlines